公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, poultry, and swine production.
公司地址 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
電話號碼 +1 877 352-6261
傳真號碼 --
公司網頁 https://www.elanco.com
員工數量 9400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 美元 1.20M 08/04/2026
Mr. Robert M. VanHimbergen Executive Vice President and Chief Financial Officer 美元 317.31K 08/04/2026
Mr. David S. Kinard Executive Vice President, Human Resources, Corporate Communications and Administration. -- 08/04/2026
Mr. Ramiro Martin Cabral Executive Vice President and President of Elanco International 美元 650.00K 08/04/2026
Mr. James M. Meer Senior Vice President and Chief Accounting Officer -- 08/04/2026
Mr. Timothy J. Bettington Executive Vice President, Center of Strategic Growth 美元 656.00K 08/04/2026
Mr. Jose Manuel Correia de Simas, PhD Executive Vice President, U.S. Farm Animal Business -- 08/04/2026
Ms. Ellen de Brabander, PhD Executive Vice President, Innovation and Regulatory Affairs 美元 847.83K 08/04/2026
Mr. Rajeev A. Modi Executive Vice President, U.S. Pet Health and Global Digital Transformation -- 08/04/2026
Ms. Grace McArdle Executive Vice President, Manufacturing and Quality -- 08/04/2026
Ms. Shiv O'Neill Executive Vice President, General Counsel and Corporate Secretary -- 08/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Art A. Garcia Independent Director 08/04/2026
Mr. Lawrence E. Kurzius Chairman of the Board 08/04/2026
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 08/04/2026
Mr. Paul S. Herendeen Independent Director 08/04/2026
Mr. Michael J. Harrington Independent Director 08/04/2026
Dr. Denise Vera Scots-Knight, PhD Independent Director 08/04/2026
Ms. Kapila Kapur Anand Independent Director 08/04/2026
Mr. Kirk McDonald Independent Director 08/04/2026
Dr. Stacey Ma, PhD Independent Director 08/04/2026
 
所屬ETF (更新日期: 07/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
RADDAB US Research Advanced ETF0.00004%30/10/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.00001%30/10/2026
BKSEBNY Mellon US Small Cap Core Equity ETF<0.000001%07/08/2025
BTALAGF U.S. Market Neutral Anti-Beta<0.000001%01/09/2026
CDEICalvert US Large-Cp Div, Eq AndIncETF<0.000001%30/10/2026
CDXSimplify High Yield ETF<0.000001%30/09/2026
IWLGNYLIM Winslow Large Cap Growth ETF<0.000001%31/08/2026
MHIGMilliman Healthcare Inflation Guard ETF<0.000001%20/10/2026
MHIPMilliman Healthcare Inflation Plus ETF<0.000001%20/10/2026
PJUSPGIM Jennison U.S. Core Equity ETF<0.000001%01/09/2026
RALSProShares RAFI® Long/Short<0.000001%30/04/2022
SHRTGotham Short Strategies ETF<0.000001%03/09/2026
SUSLiShares ESG MSCI USA Leaders ETF<0.000001%31/05/2023
TACUT. Rowe Price Active Core U.S. Eq ETF<0.000001%25/09/2026
TIMEClockwise U.S. Core Equity ETF<0.000001%22/09/2026
  1    2    3    4    5    6    7   8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.